146 related articles for article (PubMed ID: 7047017)
1. Pathogenesis of mineralocorticoid hypertension.
Schalekamp MA; Wenting GJ; Man in 't Veld AJ
Clin Endocrinol Metab; 1981 Nov; 10(3):397-418. PubMed ID: 7047017
[No Abstract] [Full Text] [Related]
2. Aldosterone, the adrenal cortex, and hypertension.
Ehrlich EN
Annu Rev Med; 1968; 19():373-98. PubMed ID: 4871694
[No Abstract] [Full Text] [Related]
3. Adrenal mineralocorticoids causing hypertension.
Biglieri EG; Stockigt JR; Schambelan M
Am J Med; 1972 May; 52(5):623-32. PubMed ID: 4556934
[No Abstract] [Full Text] [Related]
4. The use of spironolactone in the diagnosis and the treatment of hypertension associated with mineralocorticoid excess.
Beevers DG; Brown JJ; Ferriss JB; Fraser R; Lever AF; Robertson JI
Am Heart J; 1973 Sep; 86(3):404-14. PubMed ID: 4592546
[No Abstract] [Full Text] [Related]
5. Aldosterone: review of its physiology and diagnostic aspects of primary aldosteronism.
Horton R
Metabolism; 1973 Dec; 22(12):1525-45. PubMed ID: 4357694
[No Abstract] [Full Text] [Related]
6. Identification and implications of new types of mineralocorticoid hypertension.
Biglieri EG; Irony I; Kater CE
J Steroid Biochem; 1989 Jan; 32(1B):199-204. PubMed ID: 2913410
[TBL] [Abstract][Full Text] [Related]
7. The role of adrenal mineralocorticoids in hypertension.
Tuck M
Geriatrics; 1978 Jan; 33(1):77-83. PubMed ID: 620928
[No Abstract] [Full Text] [Related]
8. The diagnostic and therapeutic value of spironolactone in patients with systemic hypertension.
Burden RP; Booth LJ; Aber GM
Nephron; 1973; 9(3):171-88. PubMed ID: 4682245
[No Abstract] [Full Text] [Related]
9. [Primary aldosteronism--aldosterone-induced sodium storing hypertension--symptoms and differential diagnosis].
Ibayashi H; Takasugi M
Nihon Rinsho; 1979; 37(2):324-32. PubMed ID: 374791
[No Abstract] [Full Text] [Related]
10. A preliminary evaluation for primary aldosteronism.
Biglieri EG; Stockigt JR; Schambelan M
Arch Intern Med; 1970 Dec; 126(6):1004-7. PubMed ID: 5483593
[No Abstract] [Full Text] [Related]
11. High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients.
Stowasser M; Gordon RD; Gunasekera TG; Cowley DC; Ward G; Archibald C; Smithers BM
J Hypertens; 2003 Nov; 21(11):2149-57. PubMed ID: 14597859
[TBL] [Abstract][Full Text] [Related]
12. Abnormal regulation of aldosterone in hypertension.
Luetscher JA; Ganguly A; Melada GA; Dowdy AJ
Adv Intern Med; 1975; 20():183-96. PubMed ID: 163569
[No Abstract] [Full Text] [Related]
13. [Hypertension and steroid hormones].
Miyamori I
Nihon Rinsho; 1997 Aug; 55(8):1977-81. PubMed ID: 9284410
[TBL] [Abstract][Full Text] [Related]
14. Essential hypertension--why idiopathic?
Shapiro AP
Am J Med; 1973 Jan; 54(1):1-5. PubMed ID: 4682493
[No Abstract] [Full Text] [Related]
15. Primary aldosteronism.
McGuffin WL; Gunnells JC
Urol Clin North Am; 1977 Jun; 4(2):227-37. PubMed ID: 331615
[No Abstract] [Full Text] [Related]
16. Recurrence of hypertension in primary aldosteronism after discontinuation of spironolactone. Time course of changes in cardiac output and body fluid volumes.
Wenting GJ; Man in 't Veld AJ; Derkx FH; Schalekamp MA
Clin Exp Hypertens A; 1982; 4(9-10):1727-48. PubMed ID: 6754151
[TBL] [Abstract][Full Text] [Related]
17. Comparison of surgery and prolonged spironolactone therapy in patients with hypertension, aldosterone excess, and low plasma renin.
Brown JJ; Davies DL; Ferriss JB; Fraser R; Haywood E; Lever AF; Robertson JI
Br Med J; 1972 Jun; 2(5816):729-34. PubMed ID: 4338668
[TBL] [Abstract][Full Text] [Related]
18. Rhabdomyolysis due to primary hyperaldosteronism.
Martínez JJ; Oliveira CL; Meneses AL; Rodríguez SA; Corrales PP; López AH; Romero FB
Endocrinol Nutr; 2009 Oct; 56(8):431-4. PubMed ID: 19959155
[TBL] [Abstract][Full Text] [Related]
19. Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease.
Laragh JH; Baer L; Brunner HR; Buhler FR; Sealey JE; Vaughan ED
Am J Med; 1972 May; 52(5):633-52. PubMed ID: 4337477
[No Abstract] [Full Text] [Related]
20. Hypertension with aldosterone excess and low plasma-renin: preoperative distinction between patients with and without adrenocortical tumour.
Ferriss JB; Brown JJ; Fraser R; Kay AW; Neville AM; O'Muircheartaigh IG; Robertson JI; Symington T; Lever AF
Lancet; 1970 Nov; 2(7681):995-1000. PubMed ID: 4098088
[No Abstract] [Full Text] [Related]
[Next] [New Search]
